Document is current

Article History

Received: 19 October 2024

Accepted: 19 December 2024

First Online: 30 December 2024

Declarations

:

: Not applicable.

: Not applicable.

: Francisco Javier Candel has received (in the last three years) honoraria for lectures and advisory boards from Advanz Pharma, Angelini, Biomerieux, Gilead, Meiji, Menarini, MSD, Pfizer, Shionogi, and Viatris. Miguel Salavert Lletí has received (in the last three years) honoraria for lectures and advisory boards from Advanz Pharma, Angelini, Janssen, Menarini, MSD, Pfizer, Shionogi, and Viatris, and educational grants from Gilead and Tedec-Meiji. Rafael Cantón has participate in educational programs sponsored by BioMeieux, Pfizer, Menarini, MSD, Shionogi, and Tedec-Meiji and participate in research studies funded by BD, BioMerieux, Cepheid, MSD, and Shionogi. Jose Luis del Pozo has received honoraria for lectures and advisory boards from Advanz Pharma, Angelini, Menarini, MSD, Pfizer, Shionogi, and GSK, and educational grants from Pfizer. Fátima Galán-Sánchez has received honoraria for lectures and advisory boards from MSD, Pfizer, Shionogi and bioMerieux, and grants from Pfizer and Menarini. Montserrat Rodríguez-Aguirregabiria has conducted consulting work for Viatris and Shionogi. MR-A has served as a speaker for Pfizer, Gilead Sciences, and Shionogi. Rafael Zaragoza has received (in the last three years) honoraria for lectures and advisory boards from Advanz Pharma, BiomeMeieux, Gilead science, MSD, Mundipharma, Pfizer, Shionogi, and Viatris, David Navarro; Alejandro Rodríguez; Juan Carlos Rodríguez;L and Borja Suberviola declare that they have no competing interests. Jose Luis del Pozo has received honoraria for lectures and advisory boards from Advanz Pharma, Angelini, Menarini, MSD, Pfizer, Shionogi, and GSK, and educational grants from Pfizer. Fátima Galán-Sánchez has received honoraria for lectures and advisory boards from MSD, Pfizer, Shionogi and bioMerieux, and grants from Pfizer and Menarini. Montserrat Rodríguez-Aguirregabiria has conducted consulting work for Viatris and Shionogi. MR-A has served as a speaker for Pfizer, Gilead Sciences, and Shionogi. Rafael Zaragoza has received (in the last three years) honoraria for lectures and advisory boards from Advanz Pharma, BiomeMeieux, Gilead science, MSD, Mundipharma, Pfizer, Shionogi, and Viatris, David Navarro; Alejandro Rodríguez; Juan Carlos Rodríguez;L and Borja Suberviola declare that they have no competing interests.